Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 116

    1.

    Alternative testing systems for evaluating noncarcinogenic, hematologic toxicity.

    Parchment RE.

    Environ Health Perspect. 1998 Apr;106 Suppl 2:541-57. Review.PMID: 9599702 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Haematotoxicology: scientific basis and regulatory aspects.

    Gribaldo L.

    Altern Lab Anim. 2002 Dec;30 Suppl 2:111-3. Review.PMID: 12513660 [PubMed - indexed for MEDLINE]Related articles

    3.

    Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests.

    Parchment RE, Gordon M, Grieshaber CK, Sessa C, Volpe D, Ghielmini M.

    Ann Oncol. 1998 Apr;9(4):357-64. Review.PMID: 9636825 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

    EFSA GMO Panel Working Group on Animal Feeding Trials.

    Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. Epub 2008 Feb 13. Review.PMID: 18328408 [PubMed - indexed for MEDLINE]Related articles

    5.

    Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics.

    Pessina A, Albella B, Bayo M, Bueren J, Brantom P, Casati S, Croera C, Gagliardi G, Foti P, Parchment R, Parent-Massin D, Schoeters G, Sibiril Y, Van Den Heuvel R, Gribaldo L.

    Toxicol Sci. 2003 Oct;75(2):355-67. Epub 2003 Jul 25.PMID: 12883091 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Relevance of clonogenic assays in hematotoxicology.

    Parent-Massin D.

    Cell Biol Toxicol. 2001;17(2):87-94. Review.PMID: 11499699 [PubMed - indexed for MEDLINE]Related articles

    7.

    In vitro tests for haematotoxicity: prediction of drug-induced myelosuppression by the CFU-GM assay.

    Pessina A, Albella B, Bayo M, Bueren J, Brantom P, Casati S, Croera C, Parchment R, Parent-Massin D, Schoeters G, Sibiri Y, Van Den Heuvel R, Gribaldo L.

    Altern Lab Anim. 2002 Dec;30 Suppl 2:75-9.PMID: 12513654 [PubMed - indexed for MEDLINE]Related articles

    8.

    Physician Education: Myelodysplastic Syndrome.

    Yoshida Y.

    Oncologist. 1996;1(4):284-287.PMID: 10388004 [PubMed - as supplied by publisher]Related articlesFree article

    9.

    In vivo-in vitro correlation of myelotoxicity of 9-methoxypyrazoloacridine (NSC-366140, PD115934) to myeloid and erythroid hematopoietic progenitors from human, murine, and canine marrow.

    Parchment RE, Volpe DA, LoRusso PM, Erickson-Miller CL, Murphy MJ Jr, Grieshaber CK.

    J Natl Cancer Inst. 1994 Feb 16;86(4):273-80.PMID: 8158681 [PubMed - indexed for MEDLINE]Related articles

    10.

    Reproduction and development.

    Spielmann H.

    Environ Health Perspect. 1998 Apr;106 Suppl 2:571-6. Review.PMID: 9599704 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Invertebrates in testing of environmental chemicals: are they alternatives?

    Lagadic L, Caquet T.

    Environ Health Perspect. 1998 Apr;106 Suppl 2:593-611. Review.PMID: 9599707 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Alternative models for toxicity testing of xenobiotics.

    Kniewald J, Kmetic I, Gaurina-Srcek V, Kniewald Z.

    Arh Hig Rada Toksikol. 2005 Jun;56(2):195-204.PMID: 15968836 [PubMed - indexed for MEDLINE]Related articles

    13.

    The use of toxicokinetic and toxicodynamic data in risk assessment: an international perspective.

    Gundert-Remy U, Sonich-Mullin C; IPCS Uncertainty and Variability Planning Workgroup and Drafting Group (International Program on Chemical Safety's).

    Sci Total Environ. 2002 Apr 8;288(1-2):3-11.PMID: 12013545 [PubMed - indexed for MEDLINE]Related articles

    14.

    TestSmart-high production volume chemicals: an approach to implementing alternatives into regulatory toxicology.

    Green S, Goldberg A, Zurlo J.

    Toxicol Sci. 2001 Sep;63(1):6-14.PMID: 11509738 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The necessity of biokinetic information in the interpretation of in vitro toxicity data.

    Blaauboer BJ.

    Altern Lab Anim. 2002 Dec;30 Suppl 2:85-91. Review.PMID: 12513656 [PubMed - indexed for MEDLINE]Related articles

    16.

    Integration of QSAR and in vitro toxicology.

    Barratt MD.

    Environ Health Perspect. 1998 Apr;106 Suppl 2:459-65.PMID: 9599692 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles.

    Sayes CM, Reed KL, Warheit DB.

    Toxicol Sci. 2007 May;97(1):163-80. Epub 2007 Feb 14.PMID: 17301066 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.

    Dent MP.

    Regul Toxicol Pharmacol. 2007 Aug;48(3):241-58. Epub 2007 Apr 12.PMID: 17512650 [PubMed - indexed for MEDLINE]Related articles

    20.

    Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance.

    Mirsalis JC, Schindler-Horvat J, Hill JR, Tomaszewski JE, Donohue SJ, Tyson CA.

    Cancer Chemother Pharmacol. 1999;44(5):395-402.PMID: 10501913 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data